EOLS (Evolus) PB Ratio: (As of Jun. 25, 2026)


EOLS Evolus Inc EOLS
71 GF Score
Price $7.11
GF Value $13.59
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Evolus PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Evolus's share price is $7.11. Evolus's Book Value per Share for the quarter that ended in Mar. 2026 was $-0.44. Hence, Evolus's PB Ratio of today is .

The historical rank and industry rank for Evolus's PB Ratio or its related term are showing as below:

During the past 11 years, Evolus's highest PB Ratio was 181.72. The lowest was 1.53. And the median was 12.46.

EOLS's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful PB Ratio only.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Evolus was 82.50% per year. The lowest was -61.10% per year. And the median was -4.80% per year.

Back to Basics: PB Ratio


Evolus  (NAS:EOLS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Evolus PB Ratio Related Terms


Evolus PB Ratio Historical Data

* Premium members only.

The historical data trend for Evolus's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolus PB Ratio Chart

Evolus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.42 22.83 0.00 126.90 0.00

Evolus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EOLS vs EBS, ELTP, AQST: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Evolus's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolus PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evolus's PB Ratio distribution charts can be found below:

* The bar in red indicates where Evolus's PB Ratio falls into.


EOLS
71GF Score
Evolus Inc EOLS
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolus PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Evolus's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=7.11/-0.437
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is Evolus (EOLS) Overvalued in 2026?

Based on GuruFocus' analysis, Evolus stock appears to be undervalued. The current stock price of $7.11 is trading 47.7% below its estimated GF Value™ of $13.59. GuruFocus considers Evolus to be Possible Value Trap.

Key valuation signals for EOLS:

  • PB Ratio:
  • GF Value™: $13.59 vs. price of $7.11 (47.7% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the EOLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evolus Business Description

Other Exchanges EVL:Germany
Address 520 Newport Center Drive, Suite 1200, Newport Beach, CA, USA, 92660
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
71GF Score

Get the complete analysis for EOLS

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.11
Price
$13.59
GF Value